http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012133783-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86c0d5a6ca737f21dcf20c2bc78015d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be27d44e6c79df0797dfe7616c43f1ce
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-30
filingDate 2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dde0e8b6cb57951c093397fbb094bb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b702da9f5bf5da16f6bca320bdfdab
publicationDate 2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012133783-A1
titleOfInvention Method for producing benzylpyrazole derivative and production intermediate thereof
abstract A production intermediate of a glucopyranosyloxypyrazole derivative which is represented by general formula (E) (wherein R 3 and R 4 are as defined below) and is useful as a therapeutic agent for diabetes or the like, and a method for producing a benzylpyrazole derivative, said method being indistrially more advantageous than conventional methods for producing a benzylpyrazole derivative, can be provided by causing a reaction of a compound represented by general formula (D) (wherein each of R 1 and R 2 represents a C 1-6 alkyl group or the like; R 3 represents a halogen atom, a C 1-6 alkoxy group or the like; and R 4 represents a hydrogen atom, a halogen atom, a C 1-6 alkoxy group or the like).
priorityDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010076524-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009502763-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228411851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4416282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3546441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226661683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244290087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128431220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66601422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66601423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492543

Total number of triples: 28.